Motivation: T-cell epitopes serve as molecular keys to initiate adaptive immune responses. Identification of T-cell epitopes is also a key step in rational vaccine design. Most available methods are driven by informatics and are critically dependent on experimentally obtained training data. Analysis of a training set from Immune Epitope Database (IEDB) for several alleles indicates that the sampling of the peptide space is extremely sparse covering a tiny fraction of the possible nonamer space, and also heavily skewed, thus restricting the range of epitope prediction.

Results: We present a new epitope prediction method that has four distinct computational modules: (i) structural modelling, estimating statistical pair-potentials and constraint derivation, (ii) implicit modelling and interaction profiling, (iii) feature representation and binding affinity prediction and (iv) use of graphical models to extract peptide sequence signatures to predict epitopes for HLA class I alleles.

Conclusions: HLaffy is a novel and efficient epitope prediction method that predicts epitopes for any Class-1 HLA allele, by estimating the binding strengths of peptide-HLA complexes which is achieved through learning pair-potentials important for peptide binding. It relies on the strength of the mechanistic understanding of peptide-HLA recognition and provides an estimate of the total ligand space for each allele. The performance of HLaffy is seen to be superior to the currently available methods.

Availability And Implementation: The method is made accessible through a webserver http://proline.biochem.iisc.ernet.in/HLaffy

Contact: : nchandra@biochem.iisc.ernet.in

Supplementary Information: Supplementary data are available at Bioinformatics online.

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btw156DOI Listing

Publication Analysis

Top Keywords

class-1 hla
8
t-cell epitopes
8
epitope prediction
8
prediction method
8
hlaffy estimating
4
peptide
4
estimating peptide
4
peptide affinities
4
affinities class-1
4
hla molecules
4

Similar Publications

Background: Little is known about the survival impacts of mitochondrial status in esophageal squamous cell carcinoma (ESCC) patients who undergo neoadjuvant chemotherapy (NAC) followed by surgery.

Methods: In total, 260 pre-NAC samples from ESCC patients were analyzed. Mitochondrial status was estimated employing an objective, immunohistochemistry-based system (Mito-score).

View Article and Find Full Text PDF

HLA class, calcineurin inhibitor levels, and the risk of graft failure in kidney recipients with donor-specific antibodies.

Front Immunol

December 2024

Transplantation Unit, Renal Division, Department of Medicine, University Health Center (CHU) of Quebec, Faculty of Medicine, Laval University, Quebec, QC, Canada.

Introduction: De novo donor-specific HLA antibody (dnDSA) are associated with poor outcomes. Whether this observation applies to both HLA class I and II dnDSA remains unclear.

Methods: We studied 1236 consecutive kidney recipients who had routine anti-HLA antibody surveillance post-transplant.

View Article and Find Full Text PDF
Article Synopsis
  • Class 1 major histocompatibility complexes (MHC-I) present peptides from both self and foreign proteins on the surface of nucleated human cells, activating CD8+ T cells when foreign peptides are recognized.
  • There is a gap in the availability of tools that can predict the binding affinity of MHC-I for antigens with post-translational modifications or unusual amino acids, which are vital for understanding immunogenicity.
  • A new machine learning model has been developed that effectively predicts the binding affinity for these modified peptides, showing strong performance metrics, and offers promising applications in designing peptide-based therapeutics.
View Article and Find Full Text PDF

Background: Major histocompatibility complex class-1-related protein (MR1), unlike human leukocyte antigen (HLA) class-1, was until recently considered to be monomorphic. MR1 presents metabolites in the context of host responses to bacterial infection. MR1-restricted TCRs specific to tumor cells have been described, raising interest in their potential therapeutic application for cancer treatment.

View Article and Find Full Text PDF
Article Synopsis
  • - The study highlights the importance of the tumor microenvironment (TME) in managing esophageal squamous cell carcinoma (ESCC) patients, focusing on the impact of immune cell status before and after neoadjuvant chemotherapy (NAC) in 264 patients.
  • - While pre-NAC TME status did not significantly affect survival, post-NAC factors like low T cell counts and high PD-L1 levels were linked to significantly poorer overall survival rates, indicating critical changes in immune response after treatment.
  • - The research suggests that patients with consistently low levels of T cells and high PD-L1 may benefit from additional treatments, such as immune checkpoint inhibitors (ICIs), emphasizing the need for better stratification based on T
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!